Stay updated on Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.

Latest updates to the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the study record content remains unchanged.SummaryDifference0.1%

- Check22 days agoChange DetectedA site-wide NIH announcement appears at the top of the page, explaining that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference0.6%

- Check28 days agoChange DetectedThe ClinicalTrials.gov site footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check35 days agoChange DetectedThe study record history now includes a version submitted on 2026-10-05 documenting a Study Status update, following the version dated 2026-09-30.SummaryDifference0.4%

- Check56 days agoChange DetectedThe history list now shows a new site revision label v3.7.0, replacing the previous v3.6.6.SummaryDifference0.1%

- Check78 days agoChange DetectedOne new revision entry, Revision: v3.6.6, was added to the study history, replacing Revision: v3.6.5 and signaling an update to the record's documentation.SummaryDifference0.1%

Stay in the know with updates to Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Quizartinib in FLT3/CBL-Mutated MDS/MPN Clinical Trial page.